Report Detail

Request for Sample of this report

Pharma & Healthcare Global Biosimilars Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4742333
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 157 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Biosimilars Drug market size was valued at US$ 6141 million in 2025 and is forecast to a readjusted size of US$ 28050 million by 2032 with a CAGR of 24.5% during review period.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product"s patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Biosimilars Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biosimilars Drug market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biosimilars Drug market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biosimilars Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biosimilars Drug market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilars Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilars Drug market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biosimilars Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Insulin
Others
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
Celltrion
Pfizer
Novartis
Dr Reddy’s
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon
Wockhardt
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biosimilars Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biosimilars Drug, with revenue, gross margin, and global market share of Biosimilars Drug from 2021 to 2026.
Chapter 3, the Biosimilars Drug competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biosimilars Drug market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars Drug.
Chapter 13, to describe Biosimilars Drug research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biosimilars Drug by Type
    • 1.3.1 Overview: Global Biosimilars Drug Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Biosimilars Drug Consumption Value Market Share by Type in 2025
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Insulin
    • 1.3.5 Others
  • 1.4 Global Biosimilars Drug Market by Application
    • 1.4.1 Overview: Global Biosimilars Drug Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Biosimilars Drug Market Size & Forecast
  • 1.6 Global Biosimilars Drug Market Size and Forecast by Region
    • 1.6.1 Global Biosimilars Drug Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Biosimilars Drug Market Size by Region, (2021-2032)
    • 1.6.3 North America Biosimilars Drug Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Biosimilars Drug Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Biosimilars Drug Market Size and Prospect (2021-2032)
    • 1.6.6 South America Biosimilars Drug Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Biosimilars Drug Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Qilu Pharmaceutical
    • 2.1.1 Qilu Pharmaceutical Details
    • 2.1.2 Qilu Pharmaceutical Major Business
    • 2.1.3 Qilu Pharmaceutical Biosimilars Drug Product and Solutions
    • 2.1.4 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Qilu Pharmaceutical Recent Developments and Future Plans
  • 2.2 Bio-Thera
    • 2.2.1 Bio-Thera Details
    • 2.2.2 Bio-Thera Major Business
    • 2.2.3 Bio-Thera Biosimilars Drug Product and Solutions
    • 2.2.4 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bio-Thera Recent Developments and Future Plans
  • 2.3 Zhejiang Hisun
    • 2.3.1 Zhejiang Hisun Details
    • 2.3.2 Zhejiang Hisun Major Business
    • 2.3.3 Zhejiang Hisun Biosimilars Drug Product and Solutions
    • 2.3.4 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Zhejiang Hisun Recent Developments and Future Plans
  • 2.4 Shanghai Henlius
    • 2.4.1 Shanghai Henlius Details
    • 2.4.2 Shanghai Henlius Major Business
    • 2.4.3 Shanghai Henlius Biosimilars Drug Product and Solutions
    • 2.4.4 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Shanghai Henlius Recent Developments and Future Plans
  • 2.5 Innovent Biologics
    • 2.5.1 Innovent Biologics Details
    • 2.5.2 Innovent Biologics Major Business
    • 2.5.3 Innovent Biologics Biosimilars Drug Product and Solutions
    • 2.5.4 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Innovent Biologics Recent Developments and Future Plans
  • 2.6 Jiangsu Hengrui
    • 2.6.1 Jiangsu Hengrui Details
    • 2.6.2 Jiangsu Hengrui Major Business
    • 2.6.3 Jiangsu Hengrui Biosimilars Drug Product and Solutions
    • 2.6.4 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jiangsu Hengrui Recent Developments and Future Plans
  • 2.7 Gan&Lee
    • 2.7.1 Gan&Lee Details
    • 2.7.2 Gan&Lee Major Business
    • 2.7.3 Gan&Lee Biosimilars Drug Product and Solutions
    • 2.7.4 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Gan&Lee Recent Developments and Future Plans
  • 2.8 Tonghua Dongbao
    • 2.8.1 Tonghua Dongbao Details
    • 2.8.2 Tonghua Dongbao Major Business
    • 2.8.3 Tonghua Dongbao Biosimilars Drug Product and Solutions
    • 2.8.4 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Tonghua Dongbao Recent Developments and Future Plans
  • 2.9 United Laboratory
    • 2.9.1 United Laboratory Details
    • 2.9.2 United Laboratory Major Business
    • 2.9.3 United Laboratory Biosimilars Drug Product and Solutions
    • 2.9.4 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 United Laboratory Recent Developments and Future Plans
  • 2.10 3SBIO
    • 2.10.1 3SBIO Details
    • 2.10.2 3SBIO Major Business
    • 2.10.3 3SBIO Biosimilars Drug Product and Solutions
    • 2.10.4 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 3SBIO Recent Developments and Future Plans
  • 2.11 Luye Pharma
    • 2.11.1 Luye Pharma Details
    • 2.11.2 Luye Pharma Major Business
    • 2.11.3 Luye Pharma Biosimilars Drug Product and Solutions
    • 2.11.4 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Luye Pharma Recent Developments and Future Plans
  • 2.12 Celltrion
    • 2.12.1 Celltrion Details
    • 2.12.2 Celltrion Major Business
    • 2.12.3 Celltrion Biosimilars Drug Product and Solutions
    • 2.12.4 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Celltrion Recent Developments and Future Plans
  • 2.13 Pfizer
    • 2.13.1 Pfizer Details
    • 2.13.2 Pfizer Major Business
    • 2.13.3 Pfizer Biosimilars Drug Product and Solutions
    • 2.13.4 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Pfizer Recent Developments and Future Plans
  • 2.14 Novartis
    • 2.14.1 Novartis Details
    • 2.14.2 Novartis Major Business
    • 2.14.3 Novartis Biosimilars Drug Product and Solutions
    • 2.14.4 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Novartis Recent Developments and Future Plans
  • 2.15 Dr Reddy’s
    • 2.15.1 Dr Reddy’s Details
    • 2.15.2 Dr Reddy’s Major Business
    • 2.15.3 Dr Reddy’s Biosimilars Drug Product and Solutions
    • 2.15.4 Dr Reddy’s Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Dr Reddy’s Recent Developments and Future Plans
  • 2.16 Celgen Biopharma
    • 2.16.1 Celgen Biopharma Details
    • 2.16.2 Celgen Biopharma Major Business
    • 2.16.3 Celgen Biopharma Biosimilars Drug Product and Solutions
    • 2.16.4 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Celgen Biopharma Recent Developments and Future Plans
  • 2.17 Eli Lilly
    • 2.17.1 Eli Lilly Details
    • 2.17.2 Eli Lilly Major Business
    • 2.17.3 Eli Lilly Biosimilars Drug Product and Solutions
    • 2.17.4 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Eli Lilly Recent Developments and Future Plans
  • 2.18 Sanofi
    • 2.18.1 Sanofi Details
    • 2.18.2 Sanofi Major Business
    • 2.18.3 Sanofi Biosimilars Drug Product and Solutions
    • 2.18.4 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Sanofi Recent Developments and Future Plans
  • 2.19 Geropharm
    • 2.19.1 Geropharm Details
    • 2.19.2 Geropharm Major Business
    • 2.19.3 Geropharm Biosimilars Drug Product and Solutions
    • 2.19.4 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Geropharm Recent Developments and Future Plans
  • 2.20 Biocon
    • 2.20.1 Biocon Details
    • 2.20.2 Biocon Major Business
    • 2.20.3 Biocon Biosimilars Drug Product and Solutions
    • 2.20.4 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Biocon Recent Developments and Future Plans
  • 2.21 Wockhardt
    • 2.21.1 Wockhardt Details
    • 2.21.2 Wockhardt Major Business
    • 2.21.3 Wockhardt Biosimilars Drug Product and Solutions
    • 2.21.4 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Wockhardt Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biosimilars Drug Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Biosimilars Drug by Company Revenue
    • 3.2.2 Top 3 Biosimilars Drug Players Market Share in 2025
    • 3.2.3 Top 6 Biosimilars Drug Players Market Share in 2025
  • 3.3 Biosimilars Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Biosimilars Drug Market: Region Footprint
    • 3.3.2 Biosimilars Drug Market: Company Product Type Footprint
    • 3.3.3 Biosimilars Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biosimilars Drug Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Biosimilars Drug Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Biosimilars Drug Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Biosimilars Drug Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Biosimilars Drug Consumption Value by Type (2021-2032)
  • 6.2 North America Biosimilars Drug Market Size by Application (2021-2032)
  • 6.3 North America Biosimilars Drug Market Size by Country
    • 6.3.1 North America Biosimilars Drug Consumption Value by Country (2021-2032)
    • 6.3.2 United States Biosimilars Drug Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Biosimilars Drug Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Biosimilars Drug Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Biosimilars Drug Consumption Value by Type (2021-2032)
  • 7.2 Europe Biosimilars Drug Consumption Value by Application (2021-2032)
  • 7.3 Europe Biosimilars Drug Market Size by Country
    • 7.3.1 Europe Biosimilars Drug Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Biosimilars Drug Market Size and Forecast (2021-2032)
    • 7.3.3 France Biosimilars Drug Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Biosimilars Drug Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Biosimilars Drug Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Biosimilars Drug Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biosimilars Drug Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Biosimilars Drug Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Biosimilars Drug Market Size by Region
    • 8.3.1 Asia-Pacific Biosimilars Drug Consumption Value by Region (2021-2032)
    • 8.3.2 China Biosimilars Drug Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Biosimilars Drug Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Biosimilars Drug Market Size and Forecast (2021-2032)
    • 8.3.5 India Biosimilars Drug Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Biosimilars Drug Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Biosimilars Drug Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Biosimilars Drug Consumption Value by Type (2021-2032)
  • 9.2 South America Biosimilars Drug Consumption Value by Application (2021-2032)
  • 9.3 South America Biosimilars Drug Market Size by Country
    • 9.3.1 South America Biosimilars Drug Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Biosimilars Drug Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Biosimilars Drug Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biosimilars Drug Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Biosimilars Drug Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Biosimilars Drug Market Size by Country
    • 10.3.1 Middle East & Africa Biosimilars Drug Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Biosimilars Drug Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Biosimilars Drug Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Biosimilars Drug Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Biosimilars Drug Market Drivers
  • 11.2 Biosimilars Drug Market Restraints
  • 11.3 Biosimilars Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biosimilars Drug Industry Chain
  • 12.2 Biosimilars Drug Upstream Analysis
  • 12.3 Biosimilars Drug Midstream Analysis
  • 12.4 Biosimilars Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Biosimilars Drug. Industry analysis & Market Report on Biosimilars Drug is a syndicated market report, published as Global Biosimilars Drug Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biosimilars Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo